Web Analytics

3 Latest Announced Rounds

$1,219.99M Raised in 77 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Brixton Biosciences

start up
United States - Cambridge, MA
  • 15/05/2024
  • Series B
  • $33,000,000

Brixton Biosciences is a clinical-stage life sciences company developing novel therapies for chronic and acute pain.


Related People

Sameer SabirCo Founder

Sameer Sabir United States - Greater Boston

N/A